Global fluoroquinolone resistance epidemiology and implictions for clinical use

A Dalhoff - Interdisciplinary perspectives on infectious diseases, 2012 - Wiley Online Library
This paper on the fluoroquinolone resistance epidemiology stratifies the data according to
the different prescription patterns by either primary or tertiary caregivers and by indication …

The versatile use of exhaled volatile organic compounds in human health and disease

AW Boots, JJBN van Berkel, JW Dallinga… - Journal of breath …, 2012 - iopscience.iop.org
Exhaled breath contains thousands of volatile organic compounds (VOCs) of which the
composition varies depending on health status. Various metabolic processes within the …

Ventilación mecánica

F Gutiérrez Muñoz - Acta médica peruana, 2011 - scielo.org.pe
La ventilación mecánica (VM) es un recurso terapéutico de soporte vital, que ha contribuido
decisivamente en mejorar la sobrevida de los pacientes en estado crítico, sobre todo …

[HTML][HTML] Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition)

Y Shi, Y Huang, TT Zhang, B Cao, H Wang… - Journal of thoracic …, 2019 - ncbi.nlm.nih.gov
Pneumonia (draft)” was published in 1999 (1). Afterwards, a number of guidelines for
HAP/VAP have been published or updated at home and abroad (2-10). The definitions of …

Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography–mass spectrometry

AW Boots, A Smolinska, J Van Berkel… - Journal of breath …, 2014 - iopscience.iop.org
The identification of specific volatile organic compounds (VOCs) produced by
microorganisms may assist in developing a fast and accurate methodology for the …

Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

SY Jung, SH Lee, SY Lee, S Yang, H Noh, EK Chung… - Critical Care, 2017 - Springer
Background An optimal therapy for the treatment of pneumonia caused by drug-resistant
Acinetobacter baumannii remains unclear. This study aims to compare various antimicrobial …

Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy

M Bassetti, L Taramasso, DR Giacobbe… - Expert review of anti …, 2012 - Taylor & Francis
Ventilator-associated pneumonia (VAP) is the most frequent infection among patients
hospitalized in intensive care units, maintaining a high morbidity and mortality. The global …

[HTML][HTML] Prevention of ventilator-associated pneumonia

J Oliveira, C Zagalo, P Cavaco-Silva - Revista portuguesa de pneumologia, 2014 - Elsevier
Invasive mechanical ventilation (IMV) represents a risk factor for the development of
ventilator-associated pneumonia (VAP), which develops at least 48 h after admission in …

Risk factors for ventilator-associated pneumonia in the neonatal intensive care unit: a meta-analysis of observational studies

B Tan, F Zhang, X Zhang, YL Huang, YS Gao… - European journal of …, 2014 - Springer
Ventilator-associated pneumonia (VAP) is a common and serious problem among
mechanically ventilated patients in intensive care units (ICU), especially for the newborn …

Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated …

HS Sader, M Castanheira, RK Flamm… - International journal of …, 2015 - Elsevier
Ceftazidime/avibactam consists of ceftazidime combined with the novel non-β-lactam β-
lactamase inhibitor avibactam, which inhibits Ambler classes A, C and some D enzymes …